HNSBF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hansa Biopharma AB

Watchlist Manager

Watchlist

Price: 2.9 USD Market Closed

Market Cap: $316.6m

	Hansa Biopharma AB OTC:HNSBF	SE
A	Appen Ltd OTC:APPEF	AU
L	Levitee Labs Inc OTC:LVTTF	CA
	Guotai Junan Securities Co Ltd SSE:601211	CN
	Reliance Worldwide Corporation Ltd F:0EU	AU
N	Nanosonics Ltd F:OQS	AU
	MorphoSys AG XETRA:MOR	DE
B	Banco Bradesco SA SWB:BREC	BR
	Danske Bank A/S F:DSN	DK
	California Resources Corp NYSE:CRC	US

Profitability Summary

Hansa Biopharma AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

57%

Declining Gross Margin

68% > 60%

Negative Operating Margin

-330%

Negative 3Y Average Operating Margin

-395%

Operating Margin is Increasing

-439% > -330%

Negative Net Margin

-364%

Negative 3Y Average Net Margin

-440%

Net Margin is Increasing

-478% > -364%

Negative Free Cash Flow Margin

-291%

Negative 3Y Average Free Cash Flow Margin

-391%

Free Cash Flow Margin is Increasing

-397% > -291%

Exceptional ROE

154%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-244%

ROIC is Increasing

-326% > -144%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.